Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.61 |
| ▸ | CTSK | P43235 | 7/20 | 0.58 |
| ▸ | CTSS | P25774 | 7/20 | 0.58 |
| ▸ | CTSL | P07711 | 6/20 | 0.58 |
| ▸ | CTSB | P07858 | 4/20 | 0.58 |
| ▸ | CTRB1 | P17538 | 2/20 | 0.57 |
| ▸ | ELANE | P08246 | 2/20 | 0.57 |
| ▸ | PRTN3 | P24158 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8041576 | 0.93 | ATM (0.64) | ATMCTSKCTSSCTSLCTSB | |
| SCHEMBL20645281 | 0.89 | ATM (0.59) | ATMCTSKCTSSCTSLCTSB | |
| SCHEMBL2059369 | 0.87 | TRPM8 (0.57) | ATMCTSKCTSSCTSLCTSB | |
| SCHEMBL30946598 | 0.87 | CTSK (0.61) | ATMCTSKCTSSCTSLCTSB | |
| SCHEMBL15080869 | 0.87 | CTSK (0.61) | ATMCTSKCTSSCTSLCTSB | |
| SCHEMBL308291 | 0.86 | ATM (0.64) | ATMCTSKCTSSCTSLCTSB | |
| SCHEMBL5075275 | 0.85 | CTSK (0.60) | ATMCTSKCTSSCTSLCTSB | |
| SCHEMBL7674223 | 0.85 | MAPT (0.61) | ATMCTSKCTSSCTSLCTSB | |
| SCHEMBL5412160 | 0.85 | MAPT (0.61) | ATMCTSKCTSSCTSLCTSB | |
| SCHEMBL939737 | 0.85 | MAPT (0.61) | ATMCTSKCTSSCTSLCTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1957507-B1 | ANTIBACTERIAL 4,5-SUBSTITUTED AMINOGLYCOSIDE ANALOGS HAVING MULTIPLE SUBSTITUENTS | IONIS PHARMACEUTICALS INC (US) | 2018-10-24 | — | — | EP | disclosed |
| US-8569264-B2 | Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents | ISIS PHARMACEUTICALS, INC. (US) | 2013-10-29 | — | — | US | disclosed |
| US-20130005674-A1 | ANTIBACTERIAL 4,5-SUBSTITUTED AMINOGLYCOSIDE ANALOGS HAVING MULTIPLE SUBSTITUENTS | ISIS PHARMACEUTICALS, INC. (US) | 2013-01-03 | — | — | US | disclosed |
| US-8114856-B2 | Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents | ISIS PHARMACEUTICALS, INC. (US) | 2012-02-14 | — | — | US | disclosed |
| US-20110166334-A1 | ANTIBACTERIAL 4,5-SUBSTITUTED AMINOGLYCOSIDE ANALOGS HAVING MULTIPLE SUBSTITUENTS | ISIS PHARMACEUTICALS,INC. (US) | 2011-07-07 | — | — | US | disclosed |
| US-7943749-B2 | Antimicrobial 2-deoxystreptamine compounds | ISIS PHARMACEUTICALS, INC. (US) | 2011-05-17 | — | — | US | disclosed |
| US-7893039-B2 | Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents | ISIS PHARMACEUTICALS, INC. (US) | 2011-02-22 | — | — | US | disclosed |
| US-20080293649-A1 | ANTIBACTERIAL 4,5-SUBSTITUTED AMINOGLYCOSIDE ANALOGS HAVING MULTIPLE SUBSTITUENTS | ISIS PHARMACEUTICALS, INC. (US) | 2008-11-27 | — | — | US | disclosed |
| US-20080045468-A1 | ANTIMICROBIAL 2-DEOXYSTREPTAMINE COMPOUNDS | ISIS PHARMACEUTICALS, INC. (US) | 2008-02-21 | — | — | US | disclosed |
| EP-1809645-A1 | ANTIMICROBIAL 2-DEOXYSTREPTAMINE COMPOUNDS | Isis Pharmaceuticals, Inc. (US) | 2007-07-25 | — | — | EP | disclosed |
| US-5874061-A | PARAMAGNETIC CONTRAST AGENTS FOR BOTH NUCLEAR SPIN AND COMPUTOR TOMOGRAPHY AND MAGNETIC RESONANCE IMAGING; MARKING VASCULAR SPACE (BLOOD-POOL AGENTS); BIOCOMPATIBILITY; HIGH SIGNAL INTENSITY, THEREFORE A LOWER DOSAGE USED | SCHERING AKTIENGESELLSCHAFT (DE) | 1999-02-23 | — | — | US | disclosed |
| US-5820849-A | DIAGNOSIS WITH NUCLEAR MAGNETIC RESONANCE | SCHERING AKTIENGESELLSCHAFT (DE) | 1998-10-13 | — | — | US | disclosed |
| EP-0868202-A1 | CASCADE POLYMER COMPLEXES, PROCESS FOR PRODUCING THE SAME AND PHARMACEUTICALS CONTAINING THE SAME | SCHERING AKTIENGESELLSCHAFT (DE) | 1998-10-07 | — | — | EP | disclosed |
| EP-0836485-A2 | CASCADE POLYMER COMPLEXES | SCHERING AKTIENGESELLSCHAFT (DE) | 1998-04-22 | — | — | EP | disclosed |
| EP-0832150-A1 | CASCADE POLYMERS WITH IODINE-CONTAINING AROMATIC COMPOUNDS | SCHERING AKTIENGESELLSCHAFT (DE) | 1998-04-01 | — | — | EP | disclosed |
| WO-1997023245-A1 | CASCADE POLYMER COMPLEXES, PROCESS FOR PRODUCING THE SAME AND PHARMACEUTICALS CONTAINING THE SAME | SCHERING AKTIENGESELLSCHAFT (DE) | 1997-07-03 | — | — | WO | disclosed |
| EP-0768898-A1 | CASCADE-POLYMER COMPLEXES AND METHODS OF PRODUCING THE SAME | SCHERING AKTIENGESELLSCHAFT (DE) | 1997-04-23 | — | — | EP | disclosed |
| WO-1997002051-A2 | CASCADE POLYMER COMPLEXES | SCHERING AKTIENGESELLSCHAFT (DE) | 1997-01-23 | — | — | WO | disclosed |
| WO-1996041830-A1 | CASCADE POLYMERS WITH IODINE-CONTAINING AROMATIC COMPOUNDS | SCHERING AKTIENGESELLSCHAFT (DE) | 1996-12-27 | — | — | WO | disclosed |
| WO-1996001655-A1 | CASCADE-POLYMER COMPLEXES AND METHODS OF PRODUCING THE SAME | SCHERING AKTIENGESELLSCHAFT (DE) | 1996-01-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110166334-A1 | ANTIBACTERIAL 4,5-SUBSTITUTED AMINOGLYCOSIDE ANALOGS HAVING MULTIPLE SUBSTITUENTS | ALG8, MRPL21, AADAC | ATM 3218/4885CTSK 614/4885CTSS 724/4885 |
| US-20080293649-A1 | ANTIBACTERIAL 4,5-SUBSTITUTED AMINOGLYCOSIDE ANALOGS HAVING MULTIPLE SUBSTITUENTS | ALG8, MRPL21, AADAC | ATM 3218/4885CTSK 614/4885CTSS 724/4885 |
| US-20130005674-A1 | ANTIBACTERIAL 4,5-SUBSTITUTED AMINOGLYCOSIDE ANALOGS HAVING MULTIPLE SUBSTITUENTS | ALG8, MRPL21, AADAC | ATM 3218/4885CTSK 614/4885CTSS 724/4885 |
| US-20080045468-A1 | ANTIMICROBIAL 2-DEOXYSTREPTAMINE COMPOUNDS | MTAP, UNG, PNMT | ATM 3254/4885CTSK 736/4885CTSS 309/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.